Graduate Studies Faculty
Amy J. Eshleman, Ph.D.
Research Interests:neurotransmitter transporters; dopamine receptors; protein trafficking; therapeutics for drug and alcohol abuse parkinsons
Preceptor RotationsAcademic Term Available Summer 2016 No Fall 2016 No Winter 2016 No Spring 2016 No
Faculty MentorshipDr. Eshleman is not available as a mentor for 2016-2017.
Amy Eshleman received her Ph.D. in Toxicology at Oregon State University in 1990. She did postdoctoral research in the labs of Moshe Eldefrawi at the University of Maryland Baltimore Campus and with Aaron Janowsky at OHSU. She joined the OHSU faculty as a Lecturer with the Dept of Pharmacology, and is currently on the faculty of the Depts of Psychiatry and Behavioral Neuroscience.
Summary of Current Research
The primary area of Dr. Eshleman's research is the interactions between biogenic amine transporters and cocaine and methamphetamine. As part of this focus, Dr. Eshleman collaborates with other OHSU researchers to characterize possible therapeutics for stimulant abuse and relapse, including interactions with biogenic amine transporters, and dopamine and serotonin receptors. Dr. Eshleman is characterizing the pharmacology and biochemical effects of psychoactive substituted tryptamine and phenethylamines, substituted methcathinones, and synthetic cannabinoids. In addition, Dr. Eshleman collaborates with several OHSU researchers to identify neurotransmitter transporters and receptors expressed by bone cells, and the effect of selective serotonin reuptake inhibitors on bone density and health.